Cargando…
Effects of Combined Oxytocin and Beta-3 Receptor Agonist (CL 316243) Treatment on Body Weight and Adiposity in Male Diet-Induced Obese Rats
Previous studies have indicated that oxytocin (OT) reduces body weight in diet-induced obese (DIO) rodents through reductions in energy intake and increases in energy expenditure. We recently demonstrated that hindbrain [fourth ventricular (4V)] administration of OT evokes weight loss and elevates i...
Autores principales: | Edwards, Melise M., Nguyen, Ha K., Dodson, Andrew D., Herbertson, Adam J., Wietecha, Tomasz A., Wolden-Hanson, Tami, Graham, James L., Honeycutt, Mackenzie K., Slattery, Jared D., O’Brien, Kevin D., Havel, Peter J., Blevins, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457402/ https://www.ncbi.nlm.nih.gov/pubmed/34566687 http://dx.doi.org/10.3389/fphys.2021.725912 |
Ejemplares similares
-
Hindbrain Administration of Oxytocin Reduces Food Intake, Weight Gain and Activates Catecholamine Neurons in the Hindbrain Nucleus of the Solitary Tract in Rats
por: Anekonda, Vishwanath T., et al.
Publicado: (2021) -
CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength
por: Puzzo, Daniela, et al.
Publicado: (2016) -
The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide
por: Medak, Kyle D., et al.
Publicado: (2022) -
Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist
por: Ghorbani, Masoud, et al.
Publicado: (2015) -
Anti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C
por: Xiao, Cuiying, et al.
Publicado: (2015)